ATLAS fair value
ATLAS has no fair value for this stock today.
Bastide Le Confort Médical stock price today, ATLAS forecast and fair value
Healthcare · Medical Distribution · Euronext Paris · France
Prices as of Oct 27, 2026 · EUR
ATLAS has no fair value for this stock today.
49%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Bastide Le Confort Médical a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between €16.26 and €18.96; in 9 out of 10, between €14.19 and €21.72. Estimated annual volatility is 47%.
ATLAS does not publish a fair value for BLC.PA right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks BLC.PA has traded between €17.54 and €27.50. Today it is 36.0% below that high and 0% above its low.
On the business: net margin is 5.8%; it trades at 20.1 times earnings.
Its beta is 0.90: it moves roughly in line with the market.
Bastide Le Confort Médical SA, together with its subsidiaries, engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy.
Want to see everything about Bastide Le Confort Médical?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Bastide Le Confort Médical SA, together with its subsidiaries, engages in the sale and rental of medical equipment in France, the United Kingdom, Belgium, Spain, Canada, the Netherlands, and Italy.
49%: close to a coin flip. In half of the simulated outcomes, BLC.PA ends the month between €16.26 and €18.96.
Bastide Le Confort Médical's market capitalization is €135M. Its price-to-earnings (P/E) ratio is 20.1: you pay €20.1 for each €1.00 of yearly earnings.
ATLAS estimates annual volatility at 47%. In a typical month, half of the outcomes end between €16.26 and €18.96.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy